Literature DB >> 29454040

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

Bronwen E Shaw1, Brent R Logan2, Stephen R Spellman3, Steven G E Marsh4, James Robinson4, Joseph Pidala5, Carolyn Hurley6, Juliet Barker7, Martin Maiers3, Jason Dehn8, Hailin Wang2, Mike Haagenson3, David Porter9, Effie W Petersdorf10, Ann Woolfrey10, Mary M Horowitz2, Michael Verneris11, Katharine C Hsu7, Katharina Fleischhauer12, Stephanie J Lee13.   

Abstract

Donor factors, in addition to HLA matching status, have been associated with recipient survival in unrelated donor (URD) hematopoietic cell transplantation (HCT); however, there is no hierarchical algorithm that weights the characteristics of individual donors against each other in a quantitative manner to facilitate donor selection. The goal of this study was to develop and validate a donor selection score that prioritizes donor characteristics associated with better survival in 8/8 HLA-matched URDs. Two separate patient/donor cohorts, the first receiving HCT between 1999 and 2011 (n = 5952, c1), and the second between 2012 and 2014 (n = 4510, c2) were included in the analysis. Both cohorts were randomly spilt, 2:1, into training and testing sets. Despite studying over 10,000 URD transplants, we were unable to validate a donor selection score. The only donor characteristic associated with better survival was younger age, with 2-year survival being 3% better when a donor 10 years younger is selected. These results support previous studies suggesting prioritization of a younger 8/8 HLA-matched donor. This large dataset also shows that none of the other donor clinical factors tested were reproducibly associated with survival, and hence flexibility in selecting URDs based on other characteristics is justified. These data support a simplified URD selection process and have significant implications for URD registries.
Copyright © 2018 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Donor age; Hematopoietic cell transplant; Unrelated donor

Mesh:

Year:  2018        PMID: 29454040      PMCID: PMC5953795          DOI: 10.1016/j.bbmt.2018.02.006

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  40 in total

1.  Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

Authors:  Per Ljungman; Ronald Brand; Jennifer Hoek; Rafael de la Camara; Catherine Cordonnier; Hermann Einsele; Jan Styczynski; Katherine N Ward; Simone Cesaro
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

Review 2.  The aging immune system: primer and prospectus.

Authors:  R A Miller
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

3.  Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.

Authors:  B E Shaw; N P Mayor; R M Szydlo; W P Bultitude; C Anthias; K Kirkland; J Perry; A Clark; S Mackinnon; D I Marks; A Pagliuca; M N Potter; N H Russell; K Thomson; J A Madrigal; S G E Marsh
Journal:  Bone Marrow Transplant       Date:  2017-01-16       Impact factor: 5.483

4.  Donor choice according to age for allo-SCT for AML in complete remission.

Authors:  F Ayuk; T Zabelina; F Wortmann; H Alchalby; C Wolschke; H Lellek; U Bacher; A Zander; N Kröger
Journal:  Bone Marrow Transplant       Date:  2013-02-18       Impact factor: 5.483

5.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.

Authors:  S M Davies; C Kollman; C Anasetti; J H Antin; J Gajewski; J T Casper; A Nademanee; H Noreen; R King; D Confer; N A Kernan
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

6.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Theodore A Gooley; Mari Malkki; Andrea P Bacigalupo; Anne Cesbron; Ernette Du Toit; Gerhard Ehninger; Torstein Egeland; Gottfried F Fischer; Thibaut Gervais; Michael D Haagenson; Mary M Horowitz; Katharine Hsu; Pavel Jindra; Alejandro Madrigal; Machteld Oudshoorn; Olle Ringdén; Marlis L Schroeder; Stephen R Spellman; Jean-Marie Tiercy; Andrea Velardi; Campbell S Witt; Colm O'Huigin; Richard Apps; Mary Carrington
Journal:  Blood       Date:  2014-10-16       Impact factor: 22.113

7.  High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Authors:  Daniel Fürst; Carlheinz Müller; Vladan Vucinic; Donald Bunjes; Wolfgang Herr; Martin Gramatzki; Rainer Schwerdtfeger; Renate Arnold; Hermann Einsele; Gerald Wulf; Michael Pfreundschuh; Bertram Glass; Hubert Schrezenmeier; Klaus Schwarz; Joannis Mytilineos
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

8.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

9.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

10.  Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

View more
  24 in total

1.  Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.

Authors:  Anthony D Sung; Shekeab Jauhari; Sharareh Siamakpour-Reihani; Arati V Rao; Janet Staats; Cliburn Chan; Everett Meyer; Vijayakrishna K Gadi; Andrew B Nixon; Jing Lyu; Jichun Xie; Lauren Bohannon; Zhiguo Li; Christopher S Hourigan; Laura W Dillon; Hong Yuen Wong; Rebecca Shelby; Louis Diehl; Carlos de Castro; Thomas LeBlanc; Danielle Brander; Harry Erba; Ahmed Galal; Alexandra Stefanovic; Nelson Chao; David A Rizzieri
Journal:  Am J Hematol       Date:  2020-03-30       Impact factor: 10.047

2.  Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?

Authors:  Richard Champlin
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

3.  Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.

Authors:  Katharina Fleischhauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

5.  The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.

Authors:  Julia Pingel; Tao Wang; Yvonne Hagenlocher; Camila J Hernández-Frederick; Arnon Nagler; Michael D Haagenson; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Stephanie J Lee; Mohamad Mohty; Emmanuelle Polge; Stephen R Spellman; Alexander H Schmidt; Jon J van Rood
Journal:  Bone Marrow Transplant       Date:  2018-10-02       Impact factor: 5.483

6.  Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.

Authors:  Michael R Verneris; Jeffrey S Miller; Katherine C Hsu; Tao Wang; Jennifer A Sees; Sophie Paczesny; Hemalatha Rangarajan; Dean A Lee; Stephen R Spellman; Stephanie J Lee
Journal:  Blood Adv       Date:  2020-04-14

7.  Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning.

Authors:  Brent R Logan; Martin J Maiers; Rodney A Sparapani; Purushottam W Laud; Stephen R Spellman; Robert E McCulloch; Bronwen E Shaw
Journal:  JCO Clin Cancer Inform       Date:  2021-05

8.  Prostaglandin E2 Enhances Aged Hematopoietic Stem Cell Function.

Authors:  Andrea M Patterson; P Artur Plett; Carol H Sampson; Edward Simpson; Yunlong Liu; Louis M Pelus; Christie M Orschell
Journal:  Stem Cell Rev Rep       Date:  2021-05-11       Impact factor: 5.739

9.  Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.

Authors:  Edward W Li; Anna Lee; Maryam Vaseghi-Shanjani; Alexander Anagnostopoulos; Gabriele Jagelaviciute; Elena Kum; Tanya Petraszko; Heidi Elmoazzen; David Allan; Warren Fingrut
Journal:  Transfusion       Date:  2020-12-02       Impact factor: 3.157

10.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.